Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 1,493 | 7,221 | 126,725 | 5,263 | 5,718 |
| Gross Profit | 1,493 | 7,221 | 126,725 | 5,263 | 5,718 |
| Operating Expenses | 57,244 | 56,653 | 58,318 | 53,405 | 41,044 |
| Operating Income | -55,751 | -49,432 | 68,407 | -48,142 | -35,326 |
| Interest Expense | 912 | 738 | 744 | 732 | 696 |
| Other Income | 39 | 169 | 555 | 544 | 557 |
| Pre-tax Income | -56,624 | -50,001 | 68,218 | -48,330 | -35,465 |
| Net Income Continuous | -56,624 | -50,001 | 68,218 | -48,330 | -35,465 |
| Net Income | $-56,624 | $-50,001 | $68,218 | $-48,330 | $-35,465 |
| EPS Basic Total Ops | -12.20 | -10.80 | 14.80 | -10.60 | -7.80 |
| EPS Basic Continuous Ops | -12.29 | -10.88 | 14.87 | -10.55 | -7.75 |
| EPS Diluted Total Ops | -12.20 | -10.40 | 14.40 | -10.60 | -7.80 |
| EPS Diluted Continuous Ops | -12.29 | -10.38 | 14.37 | -10.55 | -7.75 |
| EBITDA(a) | $-53,735 | $-47,321 | $70,543 | $-45,863 | $-32,881 |